130 related articles for article (PubMed ID: 9073389)
1. A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells.
Zhang K; Sikut R; Hansson GC
Cell Immunol; 1997 Mar; 176(2):158-65. PubMed ID: 9073389
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.
Zhang K; Baeckström D; Brevinge H; Hansson GC
Tumour Biol; 1997; 18(3):175-87. PubMed ID: 9143414
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
4. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
Zhang K; Baeckström D; Brevinge H; Hansson GC
J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
[TBL] [Abstract][Full Text] [Related]
5. Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line.
Baeckström D
J Biol Chem; 1997 Apr; 272(17):11503-9. PubMed ID: 9111064
[TBL] [Abstract][Full Text] [Related]
6. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line.
Baeckström D; Zhang K; Asker N; Rüetschi U; Ek M; Hansson GC
J Biol Chem; 1995 Jun; 270(23):13688-92. PubMed ID: 7775421
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of CD43 on human natural killer cells.
Aguado E; Santamaría M; Gallego MD; Peña J; Molina IJ
J Leukoc Biol; 1999 Dec; 66(6):923-9. PubMed ID: 10614773
[TBL] [Abstract][Full Text] [Related]
9. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
Ogata S; Maimonis PJ; Itzkowitz SH
Cancer Res; 1992 Sep; 52(17):4741-6. PubMed ID: 1511439
[TBL] [Abstract][Full Text] [Related]
10. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
11. Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity.
Blottière HM; Burg C; Zennadi R; Perrin P; Blanchardie P; Bara J; Meflah K; Le Pendu J
Int J Cancer; 1992 Oct; 52(4):609-18. PubMed ID: 1399144
[TBL] [Abstract][Full Text] [Related]
12. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
13. The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses.
McCann FE; Vanherberghen B; Eleme K; Carlin LM; Newsam RJ; Goulding D; Davis DM
J Immunol; 2003 Mar; 170(6):2862-70. PubMed ID: 12626536
[TBL] [Abstract][Full Text] [Related]
14. Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.
Benoist H; Joly P; Broglio C; Jeannesson P; Idoine O; Dufer J; Desplaces A
Immunol Lett; 1992 Sep; 34(1):45-55. PubMed ID: 1362185
[TBL] [Abstract][Full Text] [Related]
15. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
16. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
18. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colonic epithelium: apolar localization corresponds to malignant transformation.
Cao Y; Schlag PM; Karsten U
Virchows Arch; 1997 Sep; 431(3):159-66. PubMed ID: 9334836
[TBL] [Abstract][Full Text] [Related]
19. Expression of mucin genes and carbohydrate epitopes in 19 human colon carcinoma cell lines.
Iida S; Tsuiji H; Nemoto Y; Sano Y; Reddish MA; Irimura T
Oncol Res; 1998; 10(8):407-14. PubMed ID: 10100757
[TBL] [Abstract][Full Text] [Related]
20. Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.
Jarahian M; Watzl C; Issa Y; Altevogt P; Momburg F
Int J Cancer; 2007 Jun; 120(12):2625-34. PubMed ID: 17294447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
